Efficacy and safety of topical WBI-1001 in the treatment of atopic dermatitis: results from a phase 2A, randomized, placebo-controlled clinical trial

Arch Dermatol. 2010 Apr;146(4):446-9. doi: 10.1001/archdermatol.2010.34.
No abstract available

Publication types

  • Clinical Trial, Phase II
  • Letter
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Topical
  • Adult
  • Benzene Derivatives / administration & dosage
  • Benzene Derivatives / therapeutic use*
  • Dermatitis, Atopic / drug therapy*
  • Dermatitis, Atopic / pathology
  • Double-Blind Method
  • Drug Carriers
  • Female
  • Humans
  • Immunologic Factors / administration & dosage
  • Immunologic Factors / therapeutic use*
  • Male
  • Treatment Outcome

Substances

  • Benzene Derivatives
  • Drug Carriers
  • Immunologic Factors